Investigational drugs
Investigational drugs are those that are currently being studied in various phases of clinical trials to demonstrate safety, efficacy, side effects etc.
List of investigational drugs[edit | edit source]
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
0-9[edit | edit source]
- (+)-Naloxone
- 11β-Methyl-19-nortestosterone
- 3-Deazaneplanocin A
- 4-Chlorokynurenine
- 4-Fluorophenibut
- 9-Methyl-β-carboline
A[edit | edit source]
- ADX-71149
- AGN-241751
- AN-788
- AT-121
- AUTEN-67
- AZD-1940
- Abrilumab
- Acadesine
- Acolbifene/prasterone
- Actoxumab
- Aducanumab
- Afimoxifene
- Alanosine
- Amdoxovir
- Amitifadine
- Anacetrapib
- Anamorelin
- Anifrolumab
- Ansofaxine
- Antagomir
- Apararenone
- Apimostinel
- Apricitabine
- Arenicin
- Arketamine
- Asoprisnil
- Asunaprevir
- Aticaprant
- Azamulin
- Azeloprazole
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
B[edit | edit source]
- BAY 38-7271
- BI 224436
- BIIB-104
- BIIB033
- BIT225
- BMS-955176
- BNC-210
- BP-897
- BRL-15,572
- BRL-50481
- BTRX-335140
- Balovaptan
- Bamlanivimab
- Beclabuvir
- Bertilimumab
- Bevirimat
- Bimagrumab
- Bitopertin
- Bivatuzumab
- Bococizumab
- Branaplam
- Brasofensine
- Brilacidin
- Brincidofovir
- Brodalumab
C[edit | edit source]
- CAd3-ZEBOV
- CCG-4986
- CGS-15943
- CGS-20625
- CGS-9896
- CGTG-102
- CP-1414S
- CSP-2503
- CX-546
- CX614
- CX717
- Cabotegravir
- Cadazolid
- Capromorelin
- Casirivimab/imdevimab
- Catumaxomab
- Cebranopadol
- Cefiderocol
- Cenderitide
- Cenicriviroc
- Censavudine
- Cimlanod
- Clazakizumab
- Clenoliximab
- Clinafloxacin
- Coluracetam
- Cycloserine/lurasidone
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
D[edit | edit source]
- Dacetuzumab
- Daridorexant
- Darusentan
- Decernotinib
- Desidustat
- Dextromethadone
- Dimethandrolone undecanoate
- Dimethandrolone
- Dimethylcurcumin
- Diridavumab
- Dupilumab
E[edit | edit source]
- EC508
- EC586
- EIDD-036
- EIDD-1723
- ERDRP-0519
- EVT-101
- EVT-103
- EVT-201
- EXP-561
- Edrecolomab
- Eganelisib
- Elafibranor
- Elamipretide
- Elvucitabine
- Emapalumab
- Emixustat
- Encenicline
- Eptinezumab
- Erastin
- Ethinylestradiol/drospirenone/prasterone
- Evenamide
- Ex-Rad
- Examorelin
- Exbivirumab
- Ezutromid
F[edit | edit source]
- FGI-103
- FGI-106
- Fabunan Antiviral Injection
- Farampator
- Favipiravir
- Felvizumab
- Foliglurax
- Foravirumab
G[edit | edit source]
- GAL-021
- GSK2831781
- GW0742
- GW501516
- Galidesivir
- Ganaplacide
- Ganaxolone
- Gardiquimod
- Gepirone
- Givinostat
- Glufimet
- Golexanolone
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
H[edit | edit source]
I[edit | edit source]
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
J-K-L[edit | edit source]
- J147
- JK-05
- JNJ-39393406
- KP-1461
- Kedarcidin
- L-733,060
- LY-2459989
- LY-404187
- LY-503430
- Larazotide
- Leflutrozole
- Libivirumab
- Ligandrol
- Linzagolix
- Lu AA-33810
M-N-O[edit | edit source]
- MK-2048
- MK-608
- MP196
- Mavatrep
- Monalizumab
- Motavizumab
- NNI-351
- NV-5138
- Nebracetam
- New Drug Application
- ORG-26576
- Obiltoxaximab
- Odalasvir
- Olanzapine/samidorphan
- Olorinab
- Onasemnogene abeparvovec
- Opiranserin
- Otelixizumab
- Oxelumab
- Oxotremorine
- Oxytrex
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
P-Q-R[edit | edit source]
- PF-00446687
- PF-3845
- PH10 (drug)
- PRO 140
- PVSRIPO
- Pagibaximab
- Pankomab
- Panobacumab
- Pascolizumab
- Pemtumomab
- Perifosine
- Pidilizumab
- Pleconaril
- Ponezumab
- Poseltinib
- Priliximab
- R13 (drug)
- R7 (drug)
- RG7795
- Racivir
- Radalbuvir
- Rafivirumab
- Ralfinamide
- Ranpirnase
- Ravidasvir
- Regavirumab
- Relacorilant
- Relamorelin
- Remdesivir
- Remogliflozin etabonate
- Resminostat
- Rislenemdaz
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
S-T[edit | edit source]
- S-18986
- SCH-58261
- SEP-363856
- SM-130686
- SR9009
- SR9011
- Sabcomeline
- Samatasvir
- Saredutant
- Savolitinib
- Seladelpar
- Seliciclib
- Seltorexant
- Semapimod
- Sevirumab
- Sodelglitazar
- Solriamfetol
- Stampidine
- Suvizumab
- TOL101
- TS-121
- Tabimorelin
- Talizumab
- Taribavirin
- Tefibazumab
- Theralizumab
- Tipifarnib
- Tislelizumab
- Torcetrapib
- Triazavirin
- Trodusquemine
- Tulrampator
- Tuvirumab
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
U-Z[edit | edit source]
- Urtoxazumab
- VOLT-02
- Vaniprevir
- Vedaclidine
- Vicriviroc
- Voclosporin
- WAY-208466
- ZMapp
- Zolbetuximab
- Zoliflodacin
- Zuranolone
Drug groups | Encyclopedia | Dictionary | Cancer drugs | OTC | Alternative meds | Drugs | Medications A-Z | FDA approved products | Portal:Pharmacology
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
